Table 4.
Patients | LVI present |
LVI absent |
---|---|---|
Low-volume SLN mets (N = 23) | 20 (87%) | 3 (13%) |
Routine H&E SLN mets (N = 35) | 31 (89%) | 4 (11%) |
Routine H&E non-SLN mets (N = 6) | 5 (83%) | 1 (17%) |
Negative SLNs (N = 444) | 76 (17%) | 368 (83%) |
LVI: lymphovascular invasion; H&E: hematoxylin and eosin; mets: metastases